RxDoctor Payments Data

Catherine Frank, MD

Family Medicine · Orlando, FLNPI 1245213800

Payments from drug & device makers

$2,568in general payments, 2019–2025

Across 145 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$499
  • AbbVie$381
  • Abbott$234
  • Astellas Pharma US Inc$233
  • Boehringer Ingelheim$138
  • Pfizer$133
  • plus $950 from 26 others

What the payments were for

  • Food & beverage$2,44995%
  • Education$853%
  • Gifts$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,568 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$110,013
Medicare patients
238
Services billed
2,076

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin43$40,051
OzempicSemaglutide29$33,512
TrulicityDulaglutide13$27,507
JanuviaSitagliptin Phosphate19$25,075
MounjaroTirzepatide19$19,696
MyrbetriqMirabegron11$14,626
Atorvastatin Calcium327$3,587
SynthroidLevothyroxine Sodium47$2,772
Rosuvastatin Calcium209$2,661
Levothyroxine Sodium203$2,135
Celecoxib30$2,007
Amlodipine Besylate251$1,781
Losartan Potassium165$1,741
Gabapentin69$1,621
Famotidine88$1,611

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$66$47,20332 claims
Boehringer IngelheimJardiance$138$40,05143 claims
Novo NordiskOzempic$499$33,51229 claims
MerckJanuvia$37$25,07519 claims
Astellas Pharma US IncMyrbetriq$233$14,62611 claims
AbbVieSynthroid$381$2,77247 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$2,135203 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →